latest news

A first-ever pill for postpartum depression, zuranolone, could receive FDA approval on August 5. The fast-acting oral tablet is safe and effective for short-term use. Prioritizing maternal mental health could help reduce maternal mortality rates in the U.S. Mental health is at the forefront of the maternal healthcare crisis in the United States, with suicide accounting for 20% of postpartum deaths in the first year following childbirth. Postpartum depression (PPD) occurs in 1 in 7 pregnanciesTrusted Source but it often goes undetected during routine screenings. While most new birthing parents experience the “baby blues” for a few weeks after delivery due to a drop in the pregnancy hormone progesterone, PPD lingers for months or longer, hindering daily functioning and impacting quality of life. Now, a new first-of-its-kind drug shows promise as a fast-acting treatment for people with severe postpartum depression. A double-blind, placebo-controlled phase 3 clinical trial recently fou...